51 2 Macrophage Metabolic Reprogramming in Diabetes 32. Martinez FO, Helming L, Milde R, Varin A, Melgert BN, Draijer C, Thomas B, Fabbri M, Crawshaw A, Ho LP, et al. Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences. Blood (2013) 121:e57–e69. doi: 10.1182/ BLOOD-2012-06-436212 33. Arnold CE, Gordon P, Barker RN, Wilson HM. The activation status of human macrophages presenting antigen determines the efficiency of Th17 responses. Immunobiology (2015) 220:10– 19. doi: 10.1016/J.IMBIO.2014.09.022 34. Boorsma CE, Draijer C;, Melgert BN. Macrophage Heterogeneity in Respiratory Diseases. Mediators Inflamm (2013) 2013: doi: 10.1155/2013/769214 35. Ryszer T. Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms. (2015) doi: 10.1155/2015/816460 36. Xu X, Grijalva A, Skowronski A, van Eijk M, Serlie MJ, Ferrante AW. Obesity Activates a Program of Lysosomal-Dependent Lipid Metabolism in Adipose Tissue Macrophages Independently of Classic Activation. doi: 10.1016/j.cmet.2013.11.001 37. Kratz M, Coats BR, Hisert KB, Hagman D, Mutskov V, Peris E, Schoenfelt KQ, Kuzma JN, Larson I, Billing PS, et al. Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages. Cell Metab (2014) 20:614–625. doi: 10.1016/j. cmet.2014.08.010 38. Zeyda M, Gollinger K, Kriehuber E, Kiefer FW, Neuhofer A, Stulnig TM. Newly identified adipose tissue macrophage populations in obesity with distinct chemokine and chemokine receptor expression. International Journal of Obesity 2010 34:12 (2010) 34:1684–1694. doi: 10.1038/ ijo.2010.103 39. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. Journal of Clinical Investigation (2007) 117:175–184. doi: 10.1172/ JCI29881 40. Wentworth JM, Naselli G, Brown WA, Doyle L, Phipson B, Smyth GK, Wabitsch M, O’Brien PE, Harrison LC. Pro-Inflammatory CD11c+CD206+ Adipose Tissue Macrophages Are Associated With Insulin Resistance in Human Obesity. Diabetes (2010) 59:1648–1656. doi: 10.2337/DB090287 41. Haka AS, Barbosa-Lorenzi VC, Lee HJ, Falcone DJ, Hudis CA, Dannenberg AJ, Maxfield FR. Exocytosis of macrophage lysosomes leads to digestion of apoptotic adipocytes and foam cell formation [S]. J Lipid Res (2016) 57:980–992. doi: 10.1194/JLR.M064089 42. Talukdar S, Oh DY, Bandyopadhyay G, Li D, Xu J, McNelis J, Lu M, Li P, Yan Q, Zhu Y, et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med (2012) 18:1407–1412. doi: 10.1038/NM.2885 43. Rocha VZ, Folco EJ, Sukhova G, Shimizu K, Gotsman I, Vernon AH, Libby P. Interferon-γ, a Th1 cytokine, regulates fat inflammation: A role for adaptive immunity in obesity. Circ Res (2008) 103:467–476. doi: 10.1161/CIRCRESAHA.108.177105 44. Lee B-C, Kim M-S, Pae M, Yamamoto Y, Eberlé D, Shimada T, Kamei N, Park H-S, Sasorith S, Woo JR, et al. Adipose Natural Killer Cells Regulate Adipose Tissue Macrophages to Promote Insulin Resistance in Obesity. Cell Metab (2016) 23:685–698. doi: 10.1016/J.CMET.2016.03.002 45. Winer DA, Winer S, Shen L, Wadia PP, Yantha J, Paltser G, Tsui H, Wu P, Davidson MG, Alonso MN, et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med (2011) 17:610–617. doi: 10.1038/nm.2353 46. Castoldi A, de Souza CN, Saraiva Câmara NO, Moraes-Vieira PM. The macrophage switch in obesity development. Front Immunol (2016) 6: doi: 10.3389/fimmu.2015.00637
RkJQdWJsaXNoZXIy MTk4NDMw